During the past decade, Brantford General Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brantford General Hospital" #1 sponsor was "McMaster University" with 5 trials, followed by "Ontario Clinical Oncology Group (OCOG)" with 3 trials sponsored, "Encore Research Inc." with 1 trials sponsored, "St. Joseph's Healthcare Hamilton" with 1 trials sponsored and "UMC Utrecht" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brantford General Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator, "Australasian Kidney Trials Network" with 1 trials as a collaborator, "Australia & New Zealand Dialysis & Transplant Registry" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator and "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Brantford General Hospital" are "Breast Cancer" (2 trials), "Antibiotic-associated Diarrhea" (1 trials), "C-Difficile" (1 trials), "Cervical Intraepithelial Neoplasia" (1 trials) and "Community-acquired Pneumonia, Influenza, COVID-19" (1 trials). Many other conditions were trialed in "Brantford General Hospital" in a lesser frequency.

Most popular intervention types in "Brantford General Hospital" are "Other" (5 trials), "Drug" (4 trials), "Device" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "APBI utilizing 3D-CRT radiation" (1 trials), "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials), "Anakinra" (1 trials) and "Angiotensin Receptor Blockers" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brantford General Hospital" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Brantford General Hospital". 1 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Brantford General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Brantford General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".